You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,040,417


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,040,417
Title: Intrauterine device
Abstract:An intrauterine device including a contraceptively effective amount of non-toxic copper or zinc compound. The device is adapted to be inserted into the uterine cavity for a prolonged period of time.
Inventor(s): Zipper; Jaime A. (Santiago, CE)
Assignee: G. D. Searle & Co. (Chicago, IL)
Application Number:05/424,100
Patent Claim Types:
see list of patent claims
Compound; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using the Example of U.S. Patent 4,040,417

Introduction

When analyzing the scope and claims of a U.S. patent, it is crucial to understand the intricacies of patent law, the process of determining inventorship, and the implications of various legal and procedural aspects. This article will delve into these aspects using the example of U.S. Patent 4,040,417, although the specific details of this patent are not provided in the sources. We will generalize the analysis to cover key points relevant to any U.S. patent.

Understanding Patent Claims

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and fully supported by the description in the patent specification[3].

Types of Claims

  • Independent Claims: These stand alone and do not refer to any other claims.
  • Dependent Claims: These refer back to and further limit an independent claim.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a physical device or system.
  • Composition Claims: Describe a chemical or material composition.

Determining Inventorship

Inventorship is a critical aspect of U.S. patent law. The true and only inventors must be listed in the patent application to ensure the patent's validity[2].

Conception and Reduction to Practice

Invention is a two-step process:

  • Conception: The formation of the idea or subject matter of the patent claims.
  • Reduction to Practice: The actual creation or implementation of the invention.

Patent Term and Adjustments

The term of a patent can be affected by various factors, including Patent Term Adjustment (PTA) and terminal disclaimers.

Patent Term Adjustment (PTA)

PTA is granted to compensate for delays during the prosecution process. However, it does not extend the term of a patent past the date of a terminal disclaimer[1].

Terminal Disclaimers

These are used to overcome obviousness-type double patenting (ODP) rejections. They ensure that the patent term does not extend beyond the expiration date of an earlier patent covering the same invention[1].

Obviousness-Type Double Patenting (ODP)

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other adjustments[1].

Patent Landscape and Prior Art

The patent landscape includes all existing patents and prior art that could affect the validity or scope of a new patent.

Prior Art

Prior art includes all publicly available information that existed before the filing date of the patent application. It is crucial in determining the novelty and non-obviousness of an invention[5].

Inter Partes Review (IPR) and Ex Parte Reexamination

These are procedures that allow for the reevaluation of patent claims based on prior art.

Inter Partes Review (IPR)

IPR is a post-grant review process where a third party can challenge the validity of a patent based on prior art. The Patent Trial and Appeal Board (PTAB) makes the final decision[5].

Ex Parte Reexamination

This is a process where the patent owner or a third party can request the USPTO to reexamine a patent based on new prior art. The request must present a substantial new question of patentability[1].

Infringement and Enforcement

Patent infringement occurs when someone makes, uses, offers to sell, or sells a patented invention without authorization.

Direct Infringement

Direct infringement involves the unauthorized making, using, offering to sell, or selling of a patented invention. This is a question of fact reviewed for clear error after a bench trial[5].

Analyzing the Specifics of U.S. Patent 4,040,417

While the specific details of U.S. Patent 4,040,417 are not provided, here is how one would approach analyzing its scope and claims:

Reviewing the Patent Specification

  • Read the abstract, description, and drawings to understand the invention.
  • Identify the independent and dependent claims.

Evaluating Claim Scope

  • Analyze each claim to determine what is protected.
  • Look for any limitations or dependencies between claims.

Checking for Prior Art

  • Conduct a thorough search of prior art to ensure the invention is novel and non-obvious.
  • Review any IPR or ex parte reexamination proceedings related to the patent.

Assessing Patent Term and Adjustments

  • Determine if any PTA or terminal disclaimers have been applied.
  • Calculate the effective patent term considering these adjustments.

Key Takeaways

  • Clear Claims: Ensure patent claims are clear, concise, and fully supported by the specification.
  • Proper Inventorship: Correctly identify and list the true and only inventors.
  • Patent Term: Understand how PTA and terminal disclaimers affect the patent term.
  • Prior Art: Thoroughly search and analyze prior art to ensure novelty and non-obviousness.
  • Infringement: Be aware of what constitutes direct infringement and how to enforce patent rights.

FAQs

  1. What are the key components of a patent claim?

    • Patent claims must be clear, concise, and fully supported by the description in the patent specification. They define the scope of the invention for which protection is sought[3].
  2. How is inventorship determined in U.S. patent law?

    • Inventorship is determined by identifying who conceived the idea and reduced it to practice. The true and only inventors must be listed in the patent application[2].
  3. What is the purpose of Patent Term Adjustment (PTA)?

    • PTA is granted to compensate for delays during the prosecution process, ensuring that the patent term is not unfairly shortened due to USPTO delays[1].
  4. What is obviousness-type double patenting (ODP)?

    • ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other adjustments[1].
  5. How does Inter Partes Review (IPR) affect patent validity?

    • IPR allows a third party to challenge the validity of a patent based on prior art. The PTAB makes the final decision, which can result in the invalidation of patent claims if they are found to be unpatentable over prior art[5].

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Determining Inventorship for US Patent Applications, Oregon State University.
  3. Patent Claims Research Dataset, USPTO.
  4. Printed material manufacturing method and printed material, PubChem.
  5. United Therapeutics Corporation v. Liquidia Technologies, Inc., United States Court of Appeals for the Federal Circuit, July 24, 2023.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,040,417

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,040,417

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 941254 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.